The following study, published in Oncotarget, assesses the impact of a multidisciplinary team care program on treatment outcomes in neuroblastoma patients. The multidisciplinary team had expertise in radiology and radiation oncology, pediatric surgery, nuclear medicine, pathology, and pediatric oncology and nursing. The team met once a week to review and discuss disease diagnosis, pathology and image findings, staging, and treatment responses in patients receiving therapy. Results indicate that the multidisciplinary team approach improved survival outcomes in high-risk neuroblastoma patients, even when the same multimodal therapy protocol was used.